These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Topical agents used in the treatment of burns].
    Author: Momcilović D.
    Journal: Med Pregl; 2002; 55(3-4):109-13. PubMed ID: 12070926.
    Abstract:
    INTRODUCTION: Understanding of fluid shifts and recognition of the importance of early and appropriate fluid replacement therapy have significantly reduced mortality in the early postburn period. After the burn patient successfully passes the resuscitation period, the burn wound represents the greatest threat to survival. HISTORY: Since the dawn of civilization, man has been trying to find an agent which would help burn wounds heal, and at the same time, not harm general condition of the injured. It was not until the XX century, after the discovery of antibiotics, when this condition was fulfilled. In 1968, combining silver and sulfadiazine, Fox made silver-sulphadiazine, which is a 1% hydrosoluble cream and a superior agent in topical treatment of burns today. CURRENT TOPICAL AGENTS: None of the topical antimicrobial agents available today, alone or combined, have the characteristics of ideal prophylactic agents, but they eliminate colonization of burn wound, and invasive infections are infrequent. With an excellent spectrum of activity, low toxicity, and ease of application with minimal pain, silver-sulfadiazine is still the most frequently used topical agent. CONCLUSION: The incidence of invasive infections and overall mortality have been significantly reduced after introduction of topical burn wound antimicrobial agents into practice. In most burn patients the drug of choice for prophylaxis is silver sulfadiazine. Other agents may be useful in certain clinical situations.
    [Abstract] [Full Text] [Related] [New Search]